Skip to main content
Top
Published in: Diabetologia 1/2009

01-01-2009 | Article

Insulin sensitivity measured by the euglycaemic insulin clamp and proinsulin levels as predictors of stroke in elderly men

Authors: B. Wiberg, J. Sundström, B. Zethelius, L. Lind

Published in: Diabetologia | Issue 1/2009

Login to get access

Abstract

Aims/hypothesis

Our aim was to investigate the predictive power of a panel of variables in glucose and insulin metabolism for the incidence of stroke or transient ischaemic attacks (TIA). We hypothesised that proinsulin and insulin resistance contributes to an increase of risk for fatal and non-fatal stroke/TIA, independently of diabetes and established risk factors.

Methods

The study is based on the Uppsala Longitudinal Study of Adult Men cohort. The examinations were performed at age 70 years.

Results

In 1,151 men free from stroke at baseline, 150 developed stroke or TIA during a median follow-up of 8.8 years. In unadjusted Cox proportional hazards analyses, a 1 SD increase of a predictor variable was associated with an increased risk for stroke/TIA, e.g. plasma insulin (HR 1.19, 95% CI 1.01–1.40), fasting intact proinsulin (HR 1.28, 95% CI 1.09–1.49); whereas a 1 SD increase in insulin sensitivity measured by the euglycaemic insulin clamp method decreased the risk for stroke/TIA (HR 0.81, 95% CI 0.68–0.96). The predictive values of fasting intact proinsulin and insulin sensitivity endured but not that of plasma insulin when adjusting for diabetes. In models adjusting for diabetes, hypertension, atrial fibrillation, electrocardiographic left ventricular hypertrophy, serum cholesterol and smoking, proinsulin remained as a significant predictor of later stroke/TIA (HR 1.22, 95% CI 1.00–1.48) whereas clamp insulin sensitivity did not (HR 0.87, 95% CI 0.71–1.07).

Conclusions/interpretation

Fasting intact proinsulin level and insulin sensitivity at clamp predicted subsequent fatal and non-fatal stroke/TIA, independently of diabetes in elderly men whereas fasting insulin did not.
Literature
1.
go back to reference Kernan WN, Inzucchi SE, Viscoli CM et al (2003) Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke. Neurology 60:1447–1451PubMed Kernan WN, Inzucchi SE, Viscoli CM et al (2003) Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke. Neurology 60:1447–1451PubMed
2.
go back to reference Lindahl B, Dinesen B, Eliasson M, Roder M, Hallmans G, Stegmayr B (2000) High proinsulin levels precede first-ever stroke in a nondiabetic population. Stroke 31:2936–2941PubMed Lindahl B, Dinesen B, Eliasson M, Roder M, Hallmans G, Stegmayr B (2000) High proinsulin levels precede first-ever stroke in a nondiabetic population. Stroke 31:2936–2941PubMed
3.
go back to reference Wiberg B, Sundstrom J, Arnlov J et al (2006) Metabolic risk factors for stroke and transient ischemic attacks in middle-aged men: a community-based study with long-term follow-up. Stroke 37:2898–2903PubMedCrossRef Wiberg B, Sundstrom J, Arnlov J et al (2006) Metabolic risk factors for stroke and transient ischemic attacks in middle-aged men: a community-based study with long-term follow-up. Stroke 37:2898–2903PubMedCrossRef
4.
go back to reference Zethelius B, Hales CN, Lithell HO, Berne C (2004) Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men. Diabetes Care 27:1433–1438PubMedCrossRef Zethelius B, Hales CN, Lithell HO, Berne C (2004) Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes: a population-based, 7-year follow-up study in 70-year-old men. Diabetes Care 27:1433–1438PubMedCrossRef
5.
go back to reference Prineas R, Crow R, Blackburn H (1982) The Minnesota code manual of electrocardiographic findings standards and procedures for measurement and classification. John Wright-PSG, Inc., Littleton, MA, USA Prineas R, Crow R, Blackburn H (1982) The Minnesota code manual of electrocardiographic findings standards and procedures for measurement and classification. John Wright-PSG, Inc., Littleton, MA, USA
6.
go back to reference Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S (1960) The electrocardiogram in population studies. A classification system. Circulation 21:1160–1175PubMed Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S (1960) The electrocardiogram in population studies. A classification system. Circulation 21:1160–1175PubMed
7.
go back to reference ADA (1997) American Diabetes Association: clinical practice recommendations 1997. Diabetes Care 20(Suppl 1):S1–S70 ADA (1997) American Diabetes Association: clinical practice recommendations 1997. Diabetes Care 20(Suppl 1):S1–S70
8.
go back to reference Sobey WJ, Beer SF, Carrington CA et al (1989) Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65–66 split and 32–33 split proinsulins. Biochem J 260:535–541PubMed Sobey WJ, Beer SF, Carrington CA et al (1989) Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65–66 split and 32–33 split proinsulins. Biochem J 260:535–541PubMed
9.
go back to reference DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223PubMed
10.
go back to reference Ingelsson E, Arnlov J, Sundstrom J, Zethelius B, Vessby B, Lind L (2005) Novel metabolic risk factors for heart failure. J Am Coll Cardiol 46:2054–2060PubMedCrossRef Ingelsson E, Arnlov J, Sundstrom J, Zethelius B, Vessby B, Lind L (2005) Novel metabolic risk factors for heart failure. J Am Coll Cardiol 46:2054–2060PubMedCrossRef
11.
go back to reference Zethelius B, Byberg L, Hales CN, Lithell H, Berne C (2003) Proinsulin and acute insulin response independently predict type 2 diabetes mellitus in men—report from 27 years of follow-up study. Diabetologia 46:20–26PubMed Zethelius B, Byberg L, Hales CN, Lithell H, Berne C (2003) Proinsulin and acute insulin response independently predict type 2 diabetes mellitus in men—report from 27 years of follow-up study. Diabetologia 46:20–26PubMed
12.
go back to reference Reaven GM, Laws A (1994) Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia 37:948–952PubMedCrossRef Reaven GM, Laws A (1994) Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia 37:948–952PubMedCrossRef
13.
go back to reference Bavenholm P, Proudler A, Tornvall P et al (1995) Insulin, intact and split proinsulin, and coronary artery disease in young men. Circulation 92:1422–1429PubMed Bavenholm P, Proudler A, Tornvall P et al (1995) Insulin, intact and split proinsulin, and coronary artery disease in young men. Circulation 92:1422–1429PubMed
14.
go back to reference Haffner SM, D’Agostino R, Mykkanen L et al (1998) Proinsulin and insulin concentrations in relation to carotid wall thickness: Insulin Resistance Atherosclerosis Study. Stroke 29:1498–1503PubMed Haffner SM, D’Agostino R, Mykkanen L et al (1998) Proinsulin and insulin concentrations in relation to carotid wall thickness: Insulin Resistance Atherosclerosis Study. Stroke 29:1498–1503PubMed
15.
go back to reference Galloway JA, Hooper SA, Spradlin CT et al (1992) Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience. Diabetes Care 15:666–692PubMedCrossRef Galloway JA, Hooper SA, Spradlin CT et al (1992) Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience. Diabetes Care 15:666–692PubMedCrossRef
16.
go back to reference Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3–10PubMedCrossRef Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3–10PubMedCrossRef
17.
go back to reference Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601–2610PubMedCrossRef Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97:2601–2610PubMedCrossRef
18.
go back to reference Salonen JT, Lakka TA, Lakka HM, Valkonen VP, Everson SA, Kaplan GA (1998) Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes 47:270–275PubMedCrossRef Salonen JT, Lakka TA, Lakka HM, Valkonen VP, Everson SA, Kaplan GA (1998) Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes 47:270–275PubMedCrossRef
19.
go back to reference Gaboury CL, Simonson DC, Seely EW, Hollenberg NK, Williams GH (1994) Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension. J Clin Invest 94:2295–2300PubMedCrossRef Gaboury CL, Simonson DC, Seely EW, Hollenberg NK, Williams GH (1994) Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension. J Clin Invest 94:2295–2300PubMedCrossRef
20.
go back to reference Sartori M, Ceolotto G, Papparella I et al (2004) Effects of angiotensin II and insulin on ERK1/2 activation in fibroblasts from hypertensive patients. Am J Hypertens 17:604–610PubMedCrossRef Sartori M, Ceolotto G, Papparella I et al (2004) Effects of angiotensin II and insulin on ERK1/2 activation in fibroblasts from hypertensive patients. Am J Hypertens 17:604–610PubMedCrossRef
21.
go back to reference Lithell H, Lindgarde F, Hellsing K et al (1981) Body weight, skeletal muscle morphology, and enzyme activities in relation to fasting serum insulin concentration and glucose tolerance in 48-year-old men. Diabetes 30:19–25PubMedCrossRef Lithell H, Lindgarde F, Hellsing K et al (1981) Body weight, skeletal muscle morphology, and enzyme activities in relation to fasting serum insulin concentration and glucose tolerance in 48-year-old men. Diabetes 30:19–25PubMedCrossRef
22.
go back to reference Merlo J, Lindblad U, Pessah-Rasmussen H et al (2000) Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol 16:235–243PubMedCrossRef Merlo J, Lindblad U, Pessah-Rasmussen H et al (2000) Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol 16:235–243PubMedCrossRef
Metadata
Title
Insulin sensitivity measured by the euglycaemic insulin clamp and proinsulin levels as predictors of stroke in elderly men
Authors
B. Wiberg
J. Sundström
B. Zethelius
L. Lind
Publication date
01-01-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 1/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1171-0

Other articles of this Issue 1/2009

Diabetologia 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine